Cargando…
p53 Promotes Cytokine Expression in Melanoma to Regulate Drug Resistance and Migration
The transcription factor p53 is frequently lost during tumor development in solid tumors; however, most melanomas retain a wild type p53 protein. The presence of wild type p53 in melanoma has fueled speculation that p53 may play a neutral or pro-tumorigenic role in this disease. Here we show that p5...
Autores principales: | Pandya, Pinakin, Kublo, Lyubov, Stewart-Ornstein, Jacob |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833998/ https://www.ncbi.nlm.nih.gov/pubmed/35159215 http://dx.doi.org/10.3390/cells11030405 |
Ejemplares similares
-
Identification of universal and cell-type specific p53 DNA binding
por: Hafner, Antonina, et al.
Publicado: (2020) -
Olig2 regulates p53-mediated apoptosis, migration and invasion of melanoma cells
por: Lee, Ji Eun, et al.
Publicado: (2021) -
Down-regulation of LATS kinases alters p53 to promote cell migration
por: Furth, Noa, et al.
Publicado: (2015) -
p53 Family in Resistance to Targeted Therapy of Melanoma
por: Vlašić, Ignacija, et al.
Publicado: (2022) -
p53 Regulation by TRP2 Is Not Pervasive in Melanoma
por: Houben, Roland, et al.
Publicado: (2014)